Literature DB >> 6316716

Subacute myelo-optico-neuropathy (SMON) in Japan. With special reference to the autopsy cases.

Y Egashira, H Matsuyama.   

Abstract

Subacute myelo-optico-neuropathy (SMON) is a predominantly sensory neuropathy with peculiar clinical and histopathological features which began to appear in Japan around 1960, continued to increase and reached the highest annual incidence of 2,814 in 1959. Clioquinol or chinoform was strongly suspected as the cause of the disease because the iron chelate of chinoform was identified in the green urine of the patients. It is now believed that chinoform is the cause of SMON for the following reasons: 1) The retrospective investigation indicated that the majority of SMON patients had been given chinoform. 2) Dogs and monkeys orally given chinoform for many days in plural institutions showed exactly the same degenerative changes in the posterior and lateral funiculi of the spinal cords as the human patients. One institution obtained the same lesions also in cats. 3) The number of new patients has greatly decreased after the production and sale of chinoform were banned in September 1970. The pathology of the SMON patients and experimental chronic chinoform intoxication in animals were reviewed with some etiological comments.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6316716

Source DB:  PubMed          Journal:  Acta Pathol Jpn        ISSN: 0001-6632


  6 in total

1.  A girl with headache, confusion and green urine.

Authors:  Andreas Hufschmidt; Alexandra Krisch; I Peschen
Journal:  J Neurol       Date:  2009-03-01       Impact factor: 4.849

2.  Clioquinol inhibits dopamine-β-hydroxylase secretion and noradrenaline synthesis by affecting the redox status of ATOX1 and copper transport in human neuroblastoma SH-SY5Y cells.

Authors:  Masato Katsuyama; En Kimura; Masakazu Ibi; Kazumi Iwata; Misaki Matsumoto; Nozomi Asaoka; Chihiro Yabe-Nishimura
Journal:  Arch Toxicol       Date:  2020-10-09       Impact factor: 5.153

Review 3.  Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities.

Authors:  Neena Singh; Swati Haldar; Ajai K Tripathi; Katharine Horback; Joseph Wong; Deepak Sharma; Amber Beserra; Srinivas Suda; Charumathi Anbalagan; Som Dev; Chinmay K Mukhopadhyay; Ajay Singh
Journal:  Antioxid Redox Signal       Date:  2013-08-15       Impact factor: 8.401

Review 4.  A brief history of brain iron accumulation in Parkinson disease and related disorders.

Authors:  Paul B Foley; Dominic J Hare; Kay L Double
Journal:  J Neural Transm (Vienna)       Date:  2022-05-09       Impact factor: 3.850

5.  NQO1 protects against clioquinol toxicity.

Authors:  Jamuna Chhetri; Jem Dilek; Noel Davies; Glenn Jacobson; Robert Dallmann; Nuri Gueven
Journal:  Front Pharmacol       Date:  2022-10-04       Impact factor: 5.988

6.  National Registry of Designated Intractable Diseases in Japan: Present Status and Future Prospects.

Authors:  Yasuhiro Kanatani; Naoko Tomita; Yoko Sato; Akiko Eto; Hiroe Omoe; Hiroshi Mizushima
Journal:  Neurol Med Chir (Tokyo)       Date:  2016-09-21       Impact factor: 1.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.